Related Experiment Video
Updated: Aug 8, 2026

07:11
Treatment of Facial Deformities using 3D Planning and Printing of Patient-Specific Implants
Published on: May 23, 2020
Case reports: Epiphysiodesis in a patient with osteopetrosis
Muharrem Inan1, Gilbert Chan, J Richard Bowen
1Department of Orthopedics, Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19899, USA.
Clinical Orthopaedics and Related Research
|May 17, 2006
Summary
A minimally invasive epiphysiodesis successfully corrected significant leg-length discrepancy in a pediatric patient with osteopetrosis. This procedure offers an effective solution for limb length inequality caused by premature growth plate closure in this condition.
Area of Science:
- Orthopedics
- Pediatric Endocrinology
- Genetics
Background:
- Osteopetrosis is a rare genetic disorder characterized by impaired osteoclast function, leading to increased bone density.
- Intermediate-type osteopetrosis can present with skeletal abnormalities, including premature closure of growth plates.
- Leg-length discrepancy is a common complication, potentially causing significant functional impairment.
Observation:
- A 14-year-old female with intermediate osteopetrosis exhibited a 4.8-cm leg-length discrepancy.
- The discrepancy resulted from premature closure of the distal femoral growth plate.
- Moseley charts predicted a 7-cm discrepancy at skeletal maturity.
Findings:
- The patient underwent a successful epiphysiodesis procedure.
- Post-treatment growth was monitored and predicted using Moseley charts.
- The epiphysiodesis effectively addressed the leg-length discrepancy.
Implications:
- Percutaneous epiphysiodesis is a viable treatment for leg-length discrepancies in osteopetrosis patients.
- Early intervention can prevent long-term functional deficits.
- This case highlights the importance of accurate growth prediction and timely surgical management.
Related Concept Videos
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
What is the Skeletal System?
Overview
